Xenetic Biosciences, Inc.
XBIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001534525
No open-market purchases or sales by Xenetic Biosciences, Inc. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $442.8K in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Xenetic Biosciences, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- +3 vs. Q3 2021
- Shares held
- 1.46M
- −214.4K (−12.8%) vs. Q3 2021
- Total value
- $1.88M
- −$1.55M (−45.2%) vs. Q3 2021
- New holders
- 8
- 4 more added
- Sold out
- 5
- 5 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting XBIO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 8 | $442.8K |
| Q1 2026 | 6 | $453.0K |
| Q4 2025 | 11 | $496.6K |
| Q3 2025 | 10 | $183.7K |
| Q2 2025 | 9 | $250.2K |
| Q1 2025 | 13 | $293.1K |
| Q4 2024 | 13 | $356.1K |
| Q3 2024 | 9 | $211.6K |
| Q2 2024 | 5 | $62.0K |
| Q1 2024 | 7 | $73.8K |
| Q4 2023 | 7 | $60.7K |
| Q3 2023 | 7 | $79.4K |
| Q2 2023 | 9 | $120.4K |
| Q1 2023 | 19 | $235.3K |
| Q4 2022 | 19 | $197.6K |
| Q3 2022 | 16 | $535.0K |
| Q2 2022 | 15 | $828.0K |
| Q1 2022 | 14 | $1.07M |
| Q4 2021 | 22 | $1.88M |
| Q3 2021 | 19 | $3.43M |
| Q2 2021 | 14 | $832.2K |
| Q1 2021 | 12 | $1.22M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Xenetic Biosciences, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 616,467 | $795.0K | 0.00% | +516,490+516.6% | Added |
| Renaissance Technologies LLC | 261,223 | $337.0K | 0.00% | −157,667−37.6% | Reduced |
| Susquehanna International Group, LLP | 127,113 | $164.0K | 0.00% | +127,113 | New |
| Geode Capital Management, LLC | 90,946 | $117.0K | 0.00% | −13,207−12.7% | Reduced |
| Citadel Advisors LLC | 57,982 | $75.0K | 0.00% | +57,982 | New |
| Dimensional Fund Advisors LP | 48,755 | $63.0K | 0.00% | −13,593−21.8% | Reduced |
| Virtu Financial LLC | 45,716 | $59.0K | 0.01% | +45,716 | New |
| Simplex Trading, LLC | 44,152 | $56.0K | 0.00% | +44,152 | New |
| State Street Corp | 33,900 | $44.0K | 0.00% | 00.0% | Unchanged |
| JTC Employer Solutions Trusteee Ltd | 26,991 | $35.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 24,400 | $31.0K | 0.00% | −130,700−84.3% | Reduced |
| Steward Partners Investment Advisory, LLC | 19,000 | $25.0K | 0.00% | +19,000 | New |
| Northern Trust Corp | 17,760 | $23.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 14,039 | $18.0K | 0.00% | +14,039 | New |
| Morgan Stanley | 12,654 | $16.0K | 0.00% | +7,477+144.4% | Added |
| First Republic Investment Management, Inc. | 10,000 | $13.0K | 0.00% | +10,000 | New |
| UBS Group AG | 6,058 | $8.00K | 0.00% | +3,412+128.9% | Added |
| Advisor Group Holdings, Inc. | 600 | $1.00K | 0.00% | +600 | New |
| Tower Research Capital LLC (TRC) | 24 | $0 | 0.00% | −2,981−99.2% | Reduced |
| Northwestern Mutual Wealth Management Co | 300 | $0 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 76 | $0 | 0.00% | +27+55.1% | Added |
| Crewe Advisors LLC | 115 | $0 | 0.00% | 00.0% | Unchanged |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −578,000−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −163,070−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Brewin Dolphin Ltd | 0 | $0 | 0.00% | −106−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −97−100.0% | Sold out |